BRAIN: Development of a detailed database for collection of clinical data in patients with brain cancer

Not Applicable

Recruiting

• Conditions: Brain Tumours; Cancer - Brain

• Registration Number: ACTRN12618001959268
• Lead Sponsor: The Walter and Eliza Hall Institute of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-04
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

Histologically confirmed brain tumours including but not limited to glioma, meningioma, brain metastases and rare tumours including medulloblastoma and ependymoma.
Adults aged 18 years and above.

Exclusion Criteria

Patients with cerebral lymphoma will be excluded.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients diagnosed with brain cancer in Australia that are recurrence-free after treatment. This outcome is being assessed from each patient's medical record.[ Data will be collected at up to 6 time points for a maximum of 5 years; diagnosis, surgery, chemotherapy, radiotherapy, surveillance, and recurrence. Primary time point is at the end of the 5 year data collection period. <br><br>]

Secondary Outcome Measures

Name	Time	Method
Overall survival of patients diagnosed with brain cancer in Australia after treatment. This outcome is being assessed from each patient’s medical record.<br>[ Data will be collected at up to 6 time points for a maximum of 5 years; diagnosis, surgery, chemotherapy, radiotherapy, surveillance, and recurrence. Timepoint is at the end of the 5 year data collection period. ]